JP2022000650A5 - - Google Patents

Download PDF

Info

Publication number
JP2022000650A5
JP2022000650A5 JP2021154089A JP2021154089A JP2022000650A5 JP 2022000650 A5 JP2022000650 A5 JP 2022000650A5 JP 2021154089 A JP2021154089 A JP 2021154089A JP 2021154089 A JP2021154089 A JP 2021154089A JP 2022000650 A5 JP2022000650 A5 JP 2022000650A5
Authority
JP
Japan
Prior art keywords
biomarkers
kit
mmp
expression
degree
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021154089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022000650A (ja
Filing date
Publication date
Priority claimed from US12/403,369 external-priority patent/US8541183B2/en
Priority claimed from JP2019081332A external-priority patent/JP2019158890A/ja
Application filed filed Critical
Publication of JP2022000650A publication Critical patent/JP2022000650A/ja
Publication of JP2022000650A5 publication Critical patent/JP2022000650A5/ja
Priority to JP2024003857A priority Critical patent/JP2024024128A/ja
Priority to JP2025078265A priority patent/JP2025114736A/ja
Pending legal-status Critical Current

Links

JP2021154089A 2009-03-12 2021-09-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット Pending JP2022000650A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024003857A JP2024024128A (ja) 2009-03-12 2024-01-15 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2025078265A JP2025114736A (ja) 2009-03-12 2025-05-08 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/403,369 2009-03-12
US12/403,369 US8541183B2 (en) 2007-09-11 2009-03-12 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
US23719809P 2009-08-26 2009-08-26
US61/237,198 2009-08-26
JP2019081332A JP2019158890A (ja) 2009-03-12 2019-04-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019081332A Division JP2019158890A (ja) 2009-03-12 2019-04-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024003857A Division JP2024024128A (ja) 2009-03-12 2024-01-15 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Publications (2)

Publication Number Publication Date
JP2022000650A JP2022000650A (ja) 2022-01-04
JP2022000650A5 true JP2022000650A5 (https=) 2022-03-28

Family

ID=42729154

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011554259A Pending JP2012520469A (ja) 2009-03-12 2010-03-12 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2015151999A Active JP6250600B2 (ja) 2009-03-12 2015-07-31 非小細胞肺癌バイオマーカーを検出する方法
JP2017224257A Active JP6774925B2 (ja) 2009-03-12 2017-11-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット
JP2019081332A Pending JP2019158890A (ja) 2009-03-12 2019-04-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2021154089A Pending JP2022000650A (ja) 2009-03-12 2021-09-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2024003857A Withdrawn JP2024024128A (ja) 2009-03-12 2024-01-15 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2025078265A Pending JP2025114736A (ja) 2009-03-12 2025-05-08 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2011554259A Pending JP2012520469A (ja) 2009-03-12 2010-03-12 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2015151999A Active JP6250600B2 (ja) 2009-03-12 2015-07-31 非小細胞肺癌バイオマーカーを検出する方法
JP2017224257A Active JP6774925B2 (ja) 2009-03-12 2017-11-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット
JP2019081332A Pending JP2019158890A (ja) 2009-03-12 2019-04-22 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024003857A Withdrawn JP2024024128A (ja) 2009-03-12 2024-01-15 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
JP2025078265A Pending JP2025114736A (ja) 2009-03-12 2025-05-08 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット

Country Status (10)

Country Link
US (1) US11474104B2 (https=)
EP (4) EP3444359A1 (https=)
JP (7) JP2012520469A (https=)
KR (2) KR101900016B1 (https=)
CN (4) CN108181457B (https=)
AU (3) AU2010223911A1 (https=)
CA (2) CA3024643C (https=)
ES (1) ES2703714T3 (https=)
PL (1) PL3257953T3 (https=)
WO (1) WO2010105235A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681899C (en) 2007-03-27 2018-06-19 Immunovia Ab Methods for diagnosis of pancreatic adenocarcinoma, and biomarkers and arrays for use in the same
EP3825693A1 (en) 2011-04-29 2021-05-26 Cancer Prevention And Cure, Ltd. Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
WO2017044715A1 (en) * 2015-09-09 2017-03-16 Somalogic, Inc. Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profiles
JP6857185B2 (ja) * 2015-09-11 2021-04-14 アプタマー サイエンス インコーポレイテッドAptamer Sciences Inc. 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法
CN108473529B (zh) * 2015-11-10 2023-04-18 伦斯勒中心转化研究公司 检测和治疗肺高压的方法
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN112501140B (zh) * 2020-12-16 2022-03-18 熊猫乳品集团股份有限公司 一种生物活性多肽yfgsgfaapffivrhqllkk及其制备方法和应用
TWI796010B (zh) * 2021-11-23 2023-03-11 國立高雄大學 基質金屬蛋白酶-1胜肽拓印導電聚合物及其用途
CN117907508A (zh) * 2023-12-19 2024-04-19 查理高特(青岛)健康科技有限公司 基于代谢组学的高尿酸血症及尿酸性肾病的风险预测系统

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69837529T2 (de) 1997-02-12 2007-07-26 Electrophoretics Ltd., Cobham Proteinmarker für lungenkrebs und deren verwendung
US20070092917A1 (en) 1998-05-01 2007-04-26 Isabelle Guyon Biomarkers for screening, predicting, and monitoring prostate disease
HU229520B1 (en) 1999-02-12 2014-01-28 Scripps Research Inst Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
WO2000052054A2 (en) 1999-03-01 2000-09-08 Genentech, Inc. Antibodies for cancer therapy and diagnosis
FI990888A0 (fi) * 1999-04-20 1999-04-20 Medix Biochemica Ab Oy Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi
EP1224564A1 (en) * 1999-04-26 2002-07-24 Surromed, Inc. Phenotype and biological marker identification system
AU2001276890A1 (en) 2000-07-12 2002-01-21 Glaxo Group Limited Novel compounds
NZ528205A (en) * 2001-03-12 2006-09-29 Monogen Inc Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes
US20030190602A1 (en) 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
EP1801240A1 (en) 2001-06-05 2007-06-27 Auckland Uniservices Limited Methods and compositions for assessment of pulmonary function and disorders
US20030134339A1 (en) 2002-01-14 2003-07-17 Thomas Brown Proteomics based method for toxicology testing
JP2005522228A (ja) 2002-04-11 2005-07-28 オックスフォード グライコサイエンシス (ユーケイ) リミテッド 癌に関与するタンパク質
WO2004030511A2 (en) 2002-05-10 2004-04-15 Eastern Virginia Medical School Prostate cancer biomarkers
AU2003240495A1 (en) * 2002-06-04 2003-12-19 Incyte Corporation Diagnostics markers for lung cancer
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
CN101586155A (zh) * 2002-09-30 2009-11-25 肿瘤疗法科学股份有限公司 非小细胞肺癌的诊断方法
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
JP4723476B2 (ja) 2003-02-14 2011-07-13 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 上昇したアルギナーゼ状態を含む、低下した一酸化窒素バイオアベイラビリティに関連する状態の治療
MXPA05009251A (es) * 2003-03-04 2005-10-19 Wyeth Corp Composiciones y metodos para diagnosticar y tratar asma u otras enfermedades alergicas o inflamatorias.
CN101265254A (zh) * 2003-03-27 2008-09-17 兰肯瑙医学研究所 新型ido抑制剂及其使用方法
JP2005044330A (ja) 2003-07-24 2005-02-17 Univ Of California San Diego 弱仮説生成装置及び方法、学習装置及び方法、検出装置及び方法、表情学習装置及び方法、表情認識装置及び方法、並びにロボット装置
ATE496142T1 (de) * 2004-03-23 2011-02-15 Oncotherapy Science Inc Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
CA2561535A1 (en) 2004-03-30 2005-10-20 Eastern Virginia Medical School Lung cancer biomarkers
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US20060084126A1 (en) * 2004-10-20 2006-04-20 Onco Detectors International, Llc Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer
WO2006045318A2 (en) * 2004-10-27 2006-05-04 Aarhus Universitet Diagnosis and treatment of immune-related diseases
MX2007006441A (es) 2004-11-30 2007-08-14 Johnson & Johnson Prognosis de cancer de pulmon.
CN1300580C (zh) 2004-12-31 2007-02-14 中国人民解放军第306医院 检测肝癌血清特征蛋白的质谱模型及其制备方法和应用
GB0508863D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Peptide
US20080044420A1 (en) 2005-05-11 2008-02-21 Heavner George A Anti-IL-13 antibodies, compositions, methods and uses
US20070099239A1 (en) 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
WO2007013671A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
KR20130108481A (ko) * 2005-08-19 2013-10-02 아보트 러보러터리즈 이원 가변 도메인 면역글로불린 및 이의 용도
JPWO2007026773A1 (ja) 2005-08-31 2009-03-12 学校法人 久留米大学 医用診断処理装置
EP1941276A1 (de) 2005-10-29 2008-07-09 Bayer Technology Services GmbH Verfahren zur bestimmung eines oder mehrerer analyten in komplex zusammengesetzten proben biologischen ursprungs und dessen verwendung
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
US20080133141A1 (en) 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
KR100760518B1 (ko) 2006-07-18 2007-09-20 삼성정밀공업 주식회사 가구용 도어의 닫힘 충격 완충 장치
US7840505B2 (en) 2006-11-02 2010-11-23 George Mason Intellectual Properties, Inc. Classification tool
WO2008063413A2 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer
US8343491B2 (en) * 2006-12-18 2013-01-01 The Johns Hopkins University Anti-HIMF antibodies to treat lung diseases
JP5085927B2 (ja) 2006-12-21 2012-11-28 ウィンテックポリマー株式会社 難燃性樹脂組成物
CN101668774B (zh) * 2007-02-28 2013-06-26 诺维莫尼公司 抗干扰素诱导蛋白-10的抗体及其使用方法
AU2008236634A1 (en) 2007-04-05 2008-10-16 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
CA2681667A1 (en) 2007-05-18 2008-11-27 Duke University Serum biomarkers for the early detection of lung cancer
EP2156187A4 (en) 2007-06-15 2010-07-21 Biosite Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND / OR FORECASTING EGG CANCER AND LUNG CANCER
PL2195645T3 (pl) 2007-09-11 2014-12-31 Cancer Prevention & Cure Ltd Metoda wspomagająca diagnostykę i terapię astmy i rak płuc
US7888051B2 (en) * 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
US8541183B2 (en) * 2007-09-11 2013-09-24 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
JP5159242B2 (ja) 2007-10-18 2013-03-06 キヤノン株式会社 診断支援装置、診断支援装置の制御方法、およびそのプログラム
ES2527649T3 (es) 2007-12-10 2015-01-28 F. Hoffmann-La Roche Ag Panel de marcadores para el cáncer colorrectal
DK2240781T3 (en) 2008-01-18 2018-03-26 Harvard College METHODS FOR DETECTING DISEASE OR STATE SIGNATURES IN BODY FLUIDS
US20110245092A1 (en) 2008-03-04 2011-10-06 John Bilello Diagnosing and monitoring depression disorders based on multiple serum biomarker panels
CN101587125B (zh) 2008-05-21 2013-07-24 林标扬 高表达癌症标记物和低表达组织器官标记物组合试剂盒
CA3152591C (en) 2008-09-09 2023-08-29 Somalogic Operating Co., Inc. Lung cancer biomarkers and uses thereof
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN101988059B (zh) 2009-07-30 2014-04-02 江苏命码生物科技有限公司 胃癌检测标记物及其检测试剂盒和生物芯片
KR20140024860A (ko) 2011-02-24 2014-03-03 버밀리언, 인코포레이티드 난소암에 대한 바이오마커 패널,진단 방법 및 시험 키트
EP3825693A1 (en) 2011-04-29 2021-05-26 Cancer Prevention And Cure, Ltd. Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
WO2015066564A1 (en) 2013-10-31 2015-05-07 Cancer Prevention And Cure, Ltd. Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
US20170073763A1 (en) 2014-03-12 2017-03-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and Compositions for Assessing Patients with Non-small Cell Lung Cancer

Similar Documents

Publication Publication Date Title
JP2022000650A5 (https=)
JP7603115B2 (ja) 測定分析物を使用する、疾患診断を改善するための方法
CN105164535B (zh) 测定急性呼吸窘迫综合征(ards)相关生物标志物的方法、监测患者的ards的发展和治疗的方法
JP2024024128A (ja) 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
De Sloovere et al. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease
Dissanayake et al. Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A
WO2014150198A2 (en) Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof
US10725039B2 (en) Biomarker signatures for Lyme disease and methods of use thereof
CN106461664A (zh) 用于肺癌的循环肿瘤细胞诊断
CN105849566B (zh) 肾脏疾病生物标志物
JP2016006426A5 (https=)
Heegaard et al. Circulating antinuclear antibodies in patients with pelvic masses are associated with malignancy and decreased survival
WO2019202448A1 (en) A three-protein proteomic biomarker for prospective determination of risk for development of active tuberculosis
WO2015164616A1 (en) Biomarkers for detection of tuberculosis
US10725038B2 (en) Biomarker signatures for lyme disease differentiation and methods of use thereof
JP7547332B2 (ja) 膀胱癌の検出
Bhalerao et al. Microfluidic immunoarray for point-of-care detection of cytokines in COVID-19 patients
CN114758719A (zh) 一种结直肠癌预测系统及其应用
Wang et al. Afamin expression in breast cancer
CN114755422B (zh) 一种结直肠癌检测的生物标志物及其应用
US20240402176A1 (en) Detection of bladder cancer in males
Kahveci et al. Red cell distribution width-to-platelet count ratio is a promising predictor of functional bowel disease.
Pokrovsky et al. Multiplex analysis of ovarian cancer patients using glycan microarray
EP2534491B1 (en) Compositons and methods for predicting cardiovascular events
CN114200138A (zh) 用于诊断和分期结直肠癌的生物标记物